Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
- Status
- RECRUITING
- Phase
- PHASE2
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Window of Opportunity in Preserving Laryngeal Function Trial
- Status
- RECRUITING
- Phase
- PHASE2
Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
- Status
- RECRUITING
- Phase
- PHASE3